T. Rowe Price Investment Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$60.1M Buy
1,150,339
+170,937
+17% +$10.3M 0.04% 320
2025
Q4
$57.6M Sell
979,402
-192,445
-16% -$11.7M 0.04% 341
2025
Q3
$65.2M Sell
1,171,847
-66,248
-5% -$3.55M 0.04% 339
2025
Q2
$63.7M Buy
+1,238,095
New +$62.2M 0.04% 351
2024
Q4
Sell
-428,331
Closed -$34.2M 672
2024
Q3
$34.2M Buy
428,331
+35,404
+9% +$2.66M 0.02% 463
2024
Q2
$28.2M Buy
392,927
+251,110
+177% +$18.5M 0.02% 467
2024
Q1
$9.98M Buy
+141,817
New +$10.1M 0.01% 541

Other funds holding TECH

T. Rowe Price Investment Management's TECH Position: Q1 2026 in Review

T. Rowe Price Investment Management increased its Bio-Techne (TECH) stake by 17% in Q1 2026, buying an estimated $10.3M and bringing the position to 1,150,339 shares worth $60.1M. The position accounts for 0.04% of the portfolio, ranked #320.

T. Rowe Price Investment Management first reported a position in TECH in Q1 2024 and has held it in 7 quarters since. The position peaked at $65.2M in Q3 2025. 584 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • T. Rowe Price Investment Management held 1,150,339 shares of Bio-Techne worth $60.1M as of Q1 2026.
  • T. Rowe Price Investment Management bought 170,937 Bio-Techne shares in Q1 2026, an estimated $10.3M.
  • Bio-Techne made up 0.04% of T. Rowe Price Investment Management's portfolio in Q1 2026, its #320 holding.
  • T. Rowe Price Investment Management first reported a position in Bio-Techne in Q1 2024 and has held it in 7 quarters since.
  • T. Rowe Price Investment Management's Bio-Techne position peaked at $65.2M in Q3 2025.
  • 584 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2026, filed 15 May 2026.